Acharya Trishna, Devkota Ramesh, Bhattarai Bimbishar, Acharya Radha
Department of Pharmacy, National Model College for Advanced Learning (NMCAL), Tribhuvan University, Kathmandu, Nepal.
Research Section, Nepal Health Research Council (NHRC), Kathmandu, Nepal.
SAGE Open Med. 2017 Mar 23;5:2050312117700809. doi: 10.1177/2050312117700809. eCollection 2017.
Induction of labour is the process of initiating the labour by artificial means from 24 weeks of gestation. The main aim of this study is to find out the maternal and foetal outcomes after induction of labour with misoprostol and oxytocin beyond 37 weeks of gestation.
This was a hospital-based observational study carried out at Paropakar Maternity and Women's Hospital, Nepal. Misoprostol of 25 µg was inserted in posterior fornix of vagina or oxytocin infusion was started from 2.5 units on whom induction was decided. Maternal and foetal/neonatal outcomes were observed. Collected data were analysed using SPSS and MS Excel.
General induction rate was found to be 7.2%. In this study, post-term pregnancy was found to be the most common reason for induction of labour. Analysis of onset of labour led to the finding that mean onset of labour was much rapid in oxytocin (6.6 h) than misoprostol (13.6 h). However, there is similarity in induction-delivery interval in both groups. Overall, the rate of normal delivery and caesarean section was found to be 64.9% and 33.2%, respectively. Similarly, normal delivery within 12 h was seen in 18.4% of the patients given with misoprostol and 43.5% in oxytocin group. Foetal distress was found as the most common reason for caesarean section. The overall occurrence of maternal complication was found to be similar in misoprostol and oxytocin groups, nausea/vomiting being the most common (36.7%) complication followed by fever (24.1%). Besides this, the most common neonatal complication found in overall cases was meconium stained liquor (49.2%).
It was found that misoprostol was used most frequently for induction of labour compared to oxytocin. The onset of labour was found to be rapid in oxytocin than misoprostol. However, the occurrence of side effects was found to be similar in both misoprostol and oxytocin groups.
引产是指从妊娠24周起通过人工方法启动分娩的过程。本研究的主要目的是了解妊娠37周后使用米索前列醇和缩宫素引产的母婴结局。
这是一项在尼泊尔帕罗帕卡尔妇产医院开展的基于医院的观察性研究。对于决定引产的患者,将25μg米索前列醇置入阴道后穹窿,或从2.5单位开始静脉滴注缩宫素。观察母婴结局。使用SPSS和MS Excel对收集的数据进行分析。
总体引产率为7.2%。在本研究中,过期妊娠是引产最常见的原因。对分娩发动情况的分析发现,缩宫素组的平均分娩发动时间(6.6小时)比米索前列醇组(13.6小时)快得多。然而,两组的引产至分娩间隔相似。总体而言,顺产率和剖宫产率分别为64.9%和33.2%。同样,米索前列醇组18.4%的患者在12小时内顺产,缩宫素组为43.5%。胎儿窘迫是剖宫产最常见的原因。米索前列醇组和缩宫素组的产妇并发症总体发生率相似,恶心/呕吐是最常见的并发症(36.7%),其次是发热(24.1%)。除此之外,总体病例中最常见的新生儿并发症是羊水胎粪污染(49.2%)。
发现与缩宫素相比,米索前列醇最常用于引产。缩宫素组的分娩发动比米索前列醇组快。然而,米索前列醇组和缩宫素组的副作用发生率相似。